Building Greater Resilience in Vaccine Manufacturing – McKinsey & Company
Preparing for the next pandemic is a priority for many national public-health leaders and requires them to lay the groundwork to mount an effective vaccine response.
Decision makers could set the stage for vaccine resilience by defining what their countries and regions need; assessing the local capacity to scale production of vaccine doses; identifying gaps and weaknesses in their national and regional vaccine value chains.
Read the full article here.
WTO Updates Joint Indicative List of Critical COVID-19 Vaccine Inputs
The WTO Secretariat has updated the joint indicative list compiling information on critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines. The revised version incorporates feedback from industry and includes information on new critical inputs that have been identified.
The “Joint Indicative List of Critical COVID-19 Vaccine Inputs for Consultation” can be found here.